KELLY GETZ: Open Payments
NPI 1700481769 · ABINGDON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 20 payments from 6 companies in 2025. Trend: 2023 $233 · 2024 $302 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $297 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
| Orexo US, Inc. | 1 | $14 |
Products named: QULIPTA, UBRELVY, VRAYLAR, INGREZZA, HYMOVIS, Flucelvax, The Cologuard Plus Collection Kit, Zubsolv.
Industry payments across MD — which companies pay providers there.
